Right Lateral Positioning and Its Effect on Induction of General Anesthesia for Children

November 4, 2016 updated by: Sayed Kaoud Abd-Elshafy, Assiut University
The quality of induction with sevoflurane, along with its ability to generate optimal conditions for Laryngeal Mask Airway (LMA) insertion without supplemental opioids or muscle relaxants, has also been well documented. An ideal inhalation induction technique besides being rapid and comfortable for the patient should be economical. To achieve rapidity, use of vital capacity breaths with 8% sevoflurane is a more popular method of induction compared with the conventional incremental induction.

Study Overview

Status

Completed

Conditions

Detailed Description

100 pediatric patients (age range, 1 to 8 years) scheduled for lower abdominal surgery under anesthesia will be included. All children in both groups will be premedicated with midazolam, 0.5 mg/kg orally, about 30 minutes before the induction of anesthesia. A parent or guardian accompanied the child into the operating room to allow the child to remain calm and cooperative for inhalation induction. Before induction, pulse oximetry and electrocardiogram monitoring will be attached. For each group, inhalation induction was initiated using a face mask using "tidal volume" and "vital capacity" breathing in high sevoflurane concentration (8%).

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children aged 1 years to 8 years
  • Children with ASA class I/II and their willingness to participate in the study

Exclusion Criteria:

  • Known seizure disorder
  • Craniofacial abnormalities/difficult airway
  • Cardiopulmonary or neuromuscular defects
  • Hepatic or renal insufficiency
  • Expected difficult intravenous (IV) cannulation (eg, dark complexion, obese)
  • Catching colds during the past four weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Supine group
Anesthesia induction with sevoflurane for the patient while he is in supine position.
Anesthesia induction with sevoflurane for the patient while he is in supine position.
Active Comparator: Right lateral group
Anesthesia induction with sevoflurane for the patient while he is in right lateral position position.
Anesthesia induction with sevoflurane for the patient while he is in right lateral position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Induction time
Time Frame: an expected 30 minutes
The time from starting induction of anesthesia until successful insertion of the LMA (seconds)
an expected 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
LMA trials (Number of patients in each group required insertion of an LMA more than once)
Time Frame: an expected 60 minutes
Number of patients in each group required insertion of an LMA more than once
an expected 60 minutes
Blood pressure
Time Frame: Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes
Systolic, diastolic and mean blood pressure "mm Hg"
Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes
Heart rate
Time Frame: Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes
Heart rate "beats per minute"
Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes
Oxygen saturation
Time Frame: Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes
Oxygen saturation %
Duration of from starting induction of anesthesia till LMA an expected average of 60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: sayed abd elshafy, MD, Associate professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

January 10, 2016

First Submitted That Met QC Criteria

January 12, 2016

First Posted (Estimate)

January 13, 2016

Study Record Updates

Last Update Posted (Estimate)

November 8, 2016

Last Update Submitted That Met QC Criteria

November 4, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IRB000087118

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on supine position

Subscribe